BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 10631554)

  • 1. The B7-CD28/CTLA-4 costimulatory pathways in autoimmune disease of the central nervous system.
    Anderson DE; Sharpe AH; Hafler DA
    Curr Opin Immunol; 1999 Dec; 11(6):677-83. PubMed ID: 10631554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting the B7/CD28:CTLA-4 costimulatory system in CNS autoimmune disease.
    Karandikar NJ; Vanderlugt CL; Bluestone JA; Miller SD
    J Neuroimmunol; 1998 Aug; 89(1-2):10-8. PubMed ID: 9726820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The complexity of the B7-CD28/CTLA-4 costimulatory pathway.
    Schweitzer AN; Sharpe AH
    Agents Actions Suppl; 1998; 49():33-43. PubMed ID: 9426826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CTLA-4 and T cell activation.
    Oosterwegel MA; Greenwald RJ; Mandelbrot DA; Lorsbach RB; Sharpe AH
    Curr Opin Immunol; 1999 Jun; 11(3):294-300. PubMed ID: 10375557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD28/B7 costimulation: a review.
    Greenfield EA; Nguyen KA; Kuchroo VK
    Crit Rev Immunol; 1998; 18(5):389-418. PubMed ID: 9784967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CTLA-4-B7 interaction is sufficient to costimulate T cell clonal expansion.
    Wu Y; Guo Y; Huang A; Zheng P; Liu Y
    J Exp Med; 1997 Apr; 185(7):1327-35. PubMed ID: 9104819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes.
    Salomon B; Lenschow DJ; Rhee L; Ashourian N; Singh B; Sharpe A; Bluestone JA
    Immunity; 2000 Apr; 12(4):431-40. PubMed ID: 10795741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the B7-CD28/CTLA-4 pathway in autoimmune disease.
    Chang TT; Kuchroo VK; Sharpe AH
    Curr Dir Autoimmun; 2002; 5():113-30. PubMed ID: 11826754
    [No Abstract]   [Full Text] [Related]  

  • 9. New protein steals the show as 'costimulator' of T cells.
    Cohen J
    Science; 1993 Nov; 262(5135):844-5. PubMed ID: 7694360
    [No Abstract]   [Full Text] [Related]  

  • 10. The CD28/CTLA-4-B7 signaling pathway is involved in both allergic sensitization and tolerance induction to orally administered peanut proteins.
    van Wijk F; Nierkens S; de Jong W; Wehrens EJ; Boon L; van Kooten P; Knippels LM; Pieters R
    J Immunol; 2007 Jun; 178(11):6894-900. PubMed ID: 17513738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B7-CD28 interaction is a late acting co-stimulatory signal for human T cell responses.
    Zhang YQ; Joost van Neerven RJ; Van Gool SW; Coorevits L; de Boer M; Ceuppens JL
    Int Immunol; 1997 Aug; 9(8):1095-102. PubMed ID: 9263006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Could expression of co-stimulatory molecules on B-PBL condition the acceptance or rejection of human liver grafts?
    Minguela A; Sánchez-Bueno F; Marín L; Miras M; Pons JA; Muro M; Torío A; García-Alonso AM; Robles R; Parrilla P; Ramirez P; Alvarez-López MR
    Transplant Proc; 2001; 33(1-2):1384-5. PubMed ID: 11267338
    [No Abstract]   [Full Text] [Related]  

  • 13. Cloning of B7-2: a CTLA-4 counter-receptor that costimulates human T cell proliferation.
    Freeman GJ; Gribben JG; Boussiotis VA; Ng JW; Restivo VA; Lombard LA; Gray GS; Nadler LM
    Science; 1993 Nov; 262(5135):909-11. PubMed ID: 7694363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the CD28-B7 costimulatory pathways in T cell-dependent B cell responses.
    Hathcock KS; Hodes RJ
    Adv Immunol; 1996; 62():131-66. PubMed ID: 8781268
    [No Abstract]   [Full Text] [Related]  

  • 15. CD28 function: a balance of costimulatory and regulatory signals.
    Bour-Jordan H; Blueston JA
    J Clin Immunol; 2002 Jan; 22(1):1-7. PubMed ID: 11958588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The complexities of T-cell co-stimulation: CD28 and beyond.
    Sperling AI; Bluestone JA
    Immunol Rev; 1996 Oct; 153():155-82. PubMed ID: 9010723
    [No Abstract]   [Full Text] [Related]  

  • 17. Modulation of murine Lyme borreliosis by interruption of the B7/CD28 T-cell costimulatory pathway.
    Shanafelt MC; Kang I; Barthold SW; Bockenstedt LK
    Infect Immun; 1998 Jan; 66(1):266-71. PubMed ID: 9423867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The interaction properties of costimulatory molecules revisited.
    Collins AV; Brodie DW; Gilbert RJ; Iaboni A; Manso-Sancho R; Walse B; Stuart DI; van der Merwe PA; Davis SJ
    Immunity; 2002 Aug; 17(2):201-10. PubMed ID: 12196291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation.
    Salomon B; Bluestone JA
    Annu Rev Immunol; 2001; 19():225-52. PubMed ID: 11244036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of autoimmunity by inhibition of T cell costimulation.
    Daikh DI; Wofsy D
    Adv Exp Med Biol; 2001; 490():113-7. PubMed ID: 11505969
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.